| Literature DB >> 32961541 |
Xiaolei Xu1, Jing Dai1,2, Yuanshu Chen1, Congcong Liu1, Fei Xin1, Xinqi Zhou1, Feng Zhou1, Emmanuel A Stamatakis3,4, Shuxia Yao1, Lizhu Luo1,2, Yulan Huang5, Jinyu Wang5, Zhili Zou5, Deniz Vatansever6, Keith M Kendrick1, Bo Zhou7, Benjamin Becker8.
Abstract
Major depressive disorder (MDD) and generalized anxiety disorder (GAD) are highly prevalent and debilitating disorders. The high overlap on the symptomatic and neurobiological level led to ongoing debates about their diagnostic and neurobiological uniqueness. The present study aims to identify common and disorder-specific neuropathological mechanisms and treatment targets in MDD and GAD. To this end we combined categorical and dimensional disorder models with a fully data-driven intrinsic network-level analysis (intrinsic connectivity contrast, ICC) to resting-state fMRI data acquired in 108 individuals (n = 35 and n = 38 unmedicated patients with first-episode GAD, MDD, respectively, and n = 35 healthy controls). Convergent evidence from categorical and dimensional analyses revealed MDD-specific decreased whole-brain connectivity profiles of the medial prefrontal and dorsolateral prefrontal cortex while GAD was specifically characterized by decreased whole-brain connectivity profiles of the putamen and decreased communication of this region with the amygdala. Together, findings from the present data-driven analysis suggest that intrinsic communication of frontal regions engaged in executive functions and emotion regulation represent depression-specific neurofunctional markers and treatment targets whereas dysregulated intrinsic communication of the striato-amygdala system engaged in reinforcement-based and emotional learning processes represent GAD-specific markers.Entities:
Mesh:
Year: 2020 PMID: 32961541 PMCID: PMC8027677 DOI: 10.1038/s41386-020-00868-5
Source DB: PubMed Journal: Neuropsychopharmacology ISSN: 0893-133X Impact factor: 7.853